- Home
- RWT vs AQST Comparison
RWT vs AQST Comparison
Compare RWT & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RWT
- AQST
- Stock Information
- Founded
- RWT 1994
- AQST 2004
- Country
- RWT United States
- AQST United States
- Employees
- RWT N/A
- AQST N/A
- Industry
- RWT Real Estate Investment Trusts
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- RWT Real Estate
- AQST Health Care
- Exchange
- RWT Nasdaq
- AQST Nasdaq
- Market Cap
- RWT 734.0M
- AQST 809.3M
- IPO Year
- RWT 1995
- AQST 2018
- Fundamental
- Price
- RWT $5.25
- AQST $6.00
- Analyst Decision
- RWT Buy
- AQST Strong Buy
- Analyst Count
- RWT 8
- AQST 6
- Target Price
- RWT $7.00
- AQST $10.33
- AVG Volume (30 Days)
- RWT 1.1M
- AQST 3.1M
- Earning Date
- RWT 10-29-2025
- AQST 11-05-2025
- Dividend Yield
- RWT 13.71%
- AQST N/A
- EPS Growth
- RWT N/A
- AQST N/A
- EPS
- RWT N/A
- AQST N/A
- Revenue
- RWT $120,824,000.00
- AQST $44,132,000.00
- Revenue This Year
- RWT N/A
- AQST N/A
- Revenue Next Year
- RWT $25.80
- AQST $51.39
- P/E Ratio
- RWT N/A
- AQST N/A
- Revenue Growth
- RWT N/A
- AQST N/A
- 52 Week Low
- RWT $4.68
- AQST $2.12
- 52 Week High
- RWT $7.62
- AQST $7.55
- Technical
- Relative Strength Index (RSI)
- RWT 33.77
- AQST 43.46
- Support Level
- RWT $5.07
- AQST $6.39
- Resistance Level
- RWT $5.77
- AQST $6.93
- Average True Range (ATR)
- RWT 0.16
- AQST 0.37
- MACD
- RWT -0.03
- AQST -0.17
- Stochastic Oscillator
- RWT 25.35
- AQST 9.36
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.